Cardinal Health, Inc.
High uncertainty:The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-27.9% vs price
Base Case (Median)
3.9% vs price
Bull Case (75th pct.)
53.1% vs price
◇ = Current price | |Bear |Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $767.16 | 225.5% | High (40%) |
| PE Comparable | $160.90 | -31.7% | Medium (25%) |
| Growth Trajectory DCF | $292.90 | 24.3% | Medium (20%) |
| EV/EBITDA | $147.37 | -37.5% | Medium (20%) |
| EV/FCF | $383.47 | 62.7% | Medium (20%) |
| Earnings Power Value | $196.72 | -16.5% | Medium (50%) |
Based on 6 out of 8 methods, CAH appears fairly valued at the current price of $235.66. The base case fair value of $244.81 implies 3.9% upside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.